[发明专利]用罗达司他乙酯治疗肺动脉高压的给药方案和方法在审
申请号: | 202080016400.5 | 申请日: | 2020-01-30 |
公开(公告)号: | CN113557022A | 公开(公告)日: | 2021-10-26 |
发明(设计)人: | M·帕拉西奥斯;E·J·高克尔;S·A·玲;M·阿隆索-加力西亚 | 申请(专利权)人: | 阿尔塔万特科学公司 |
主分类号: | A61K31/506 | 分类号: | A61K31/506;A61K9/00;A61P9/12 |
代理公司: | 北京三友知识产权代理有限公司 11127 | 代理人: | 李栋修;武胐 |
地址: | 瑞士*** | 国省代码: | 暂无信息 |
权利要求书: | 查看更多 | 说明书: | 查看更多 |
摘要: | |||
搜索关键词: | 用罗达司 治疗 肺动脉 高压 药方 方法 | ||
提出了用于治疗肺动脉高压的每日给药方案。所述方案采用两种不同的剂型形式。每个剂型包括约600mg至约800mg量的(S)‑乙基8‑(2‑氨基‑6‑((R)‑1‑(5‑氯‑[1,1'‑联苯]‑2‑基)‑2,2,2‑三氟乙氧基)嘧啶‑4‑基)‑2,8‑二氮杂螺[4.5]癸烷‑3‑羧酸酯。还存在提供每日给药方案的其他方法。还提出了用于治疗肺动脉高压的数种方法。提出了一种将血清素生物合成水平降低至少50%的方法。还提出了实现AUC0‑tau≥2530ng.hr/mL(S)‑8‑(2‑氨基‑6‑((R)‑1‑(5‑氯‑[1.1'‑联苯]‑2‑基)‑2,2,2‑三氟乙氧基)嘧啶‑4‑基)‑2,8‑二氮杂螺[4.5]癸烷‑3‑羧酸的一种方法。提出了一种将尿5‑HIAA降低50%的方法。
本公开的背景
1.
本公开涉及用于治疗肺动脉高压的每日给药方案。本公开还涉及用于治疗肺动脉高压的方法。本公开进一步涉及在一段时间内降低血清素生物合成水平的方法。本公开还进一步涉及在一段时间内实现AUC0-tau水平提高的方法。本公开进一步涉及在一段时间内实现尿中5-HIAA降低的方法。
2.
血清素(5-羟色胺、5-HT)是一种神经递质,其通过作用于神经元、平滑肌和其他细胞类型来调节中枢和外周功能。5-HT参与多种生理和心理过程的控制和调节。在中枢神经系统(CNS)中,5-HT调节情绪、食欲和其他行为功能。在胃肠(GI)系统中,5-HT具有一般的促动力作用,是胃肠道和大脑之间感觉(例如,恶心和饱腹感)的重要介体。根据报告,外周5-HT信号传导系统失调与多种病症的病因有关(例如,参见:Mawe,G.M.Hoffman,J.,Serotonin Signalling in the Gut-functions,Dysfunctions and TherapeuticTargets.Nature Reviews.GastroenterologyHepatology 10,473-486(2013);Gershon,M.D.5-hydroxytryptamine(serotonin)in the Gastrointestinal Tract.CurrentOpinion in Endocrinology,Diabetes,and Obesity 20,14-21(2013);Lesurtel,M.,Soll,C,Graf,R.Ciavien,P.-A.Role of Serotonin in the Hepato-gastrointestinalTract:An Old Molecule for New Perspectives.Cellular and Molecular LifeSciences:CMLS 65,940-52(2008)。这些包括骨质疏松症(例如,Kode,A,et al.,FOXO1Orchestrates the Bone-suppressing Function of Gut-derived Serotonin,TheJournal of Clinical Investigation 122,3490-503(2012);Yadav,V,K.et al.,Pharmacological Inhibition of Gut-derived Serotonin Synthesis is a PotentialBone Anabolic Treatment for Osteoporosis.Nature Medicine 16,308-12(2010);Yadav,V.K,et al.,Lrp5 Controls Bone Formation by Inhibiting SerotoninSynthesis in the Duodenum,Cell 135,825-37(2008)、癌症(例如,Liang,C,et al.,Serotonin Promotes the Proliferation of Serum-deprived HepatocellularCarcinoma Cells Via Upregulation of FOX03a.Molecular Cancer 12,14(2013);Soil,C.et al.,Serotonin Promotes Tumor Growth in Human HepatocellularCancer.Hepatology 51,1244-1254(2010);Pai,V.P et al.,Altered SerotoninPhysiology in Human Breast Cancers Favors Paradoxical Growth and CellSurvival.Breast Cancer Research:BCR 11,R81(2009);Engelman,K.,Lovenberg,W.Sjoerdsma,A.Inhibition of Serotonin Synthesis by Para-chlorophenylalanine inPatients with The Carcinoid Syndrome.The New England Journal of Medicine 277,1103-8(1967)、心血管疾病(例如,Robiolio,P.A,et al.,Carcinoid Heart Disease:Correlation of High Serotonin Levels with Valvular Abnormalities Detected byCardiac Catheterization and Echocardiography.Circulation 92,790-795(1995)、糖尿病(例如,Sumara,G.,Sumara,O.,Kim,J.K.Karsenty,G.Gut-derived Serotonin is aMultifunctional Determinant to Fasting Adaptation.Cell Metabolism 16,588-600(2012)、动脉粥样硬化(例如,Ban,Y.et al.,Impact of Increased Plasma SerotoninLevels and Carotid Atherosclerosis on Vascular Dementia.Atherosclerosis 195,153-9(2007))以及胃肠道疾病(例如,Manocha,M.Khan,W.I.Serotonin and GIDisorders:An Update on Clinical and Experimental Studies.Clinical andTranslational Gastroenterology 3,el 3(2012);Ghia,J.-E.et al.,Serotonin has aKey Role in Pathogenesis of Experimental Colitis.Gastroenterology 137,1649-60(2009);Sikander,A.,Rana,S.V.Prasad,K.K.,Role of Serotonin inGastrointestinal Motility and Irritable Bowel Syndrome.Clinica Chimica Acta;International Journal of Clinical Chemistry403,47-55(2009);Spiller,R,RecentAdvances in Understanding the Role of Serotonin in Gastrointestinal Motilityin Functional Bowel Disorders:Alterations In 5-HT Signalling and Metabolismin Human Disease.Neurogastroenterology and Motility:The Official Journal ofThe European Gastrointestinal Motility Society 19Suppl 2,25-31(2007);Costedio,M.M.,Hyman,N.Mawe,G,M,Serotonin and its Role in Colonic Functionand In Gastrointestinal Disorders.Diseases of the Colon and Rectum 50,376-88(2007);Gershon,M.D.Tack,J.,The Serotonin Signalling System:From BasicUnderstanding to Drug Development for Functional GIDisorders.Gastroenterology 132,397-14(2007);Mawe,G.M.,Coates,M.D.Moses,P.L.Review Article:Intestinal Serotonin Signalling In Irritable BowelSyndrome.Alimentary PharmacologyTherapeutics 23,1067-76(2006);Crowell,M.D.Role of Serotonin in the Pathophysiology of The Irritable BowelSyndrome.British Journal of Pharmacology 141,1285-93(2004)、肺病(例如,Lau,W.K.W.et al.,The Role of Circulating Serotonin in the Development of ChronicObstructive Pulmonary Disease.PloS One 7,e31617(2012);Egermayer,P.,Town,G.I.Peacock,A.J.Role of Serotonin in the Pathogenesis of Acute and ChronicPulmonary Hypertension.Thorax 54,161-168(1999)、炎症性疾病(例如,Margolis,K.G.et al.,Pharmacological Reduction of Mucosal but Not Neuronal SerotoninOpposes Inflammation in Mouse Intestine.Gut doi:10.1 136/gutjnl-2013-304901(2013);Duerschmied,D.et al.,Platelet Serotonin Promotes the Recruitment ofNeutrophils to Sites of Acute Inflammation in Mice.Blood 121,1008-15(2013);Li,N.et al.,Serotonin Activates Dendritic Cell Function in the Context of GutInflammation.The American Journal of Pathology 178,662-71(2011)或肝脏疾病或失调(例如,Ebrahimkhani,M.R.et al.,Stimulating Healthy Tissue Regeneration byTargeting The 5-HT2B Receptor in Chronic Liver Disease.Nature Medicine 17,1668-73(2011)。阻断或刺激各种5-HT受体的大量药剂也提示了与5-HT失调有关的广泛医学疾病(例如,参见:Wacker,D.et al.,Structural Features for FunctionalSelectivity at Serotonin Receptors,Science(New York N Y.)340,615-9(2013)。
该专利技术资料仅供研究查看技术是否侵权等信息,商用须获得专利权人授权。该专利全部权利属于阿尔塔万特科学公司,未经阿尔塔万特科学公司许可,擅自商用是侵权行为。如果您想购买此专利、获得商业授权和技术合作,请联系【客服】
本文链接:http://www.vipzhuanli.com/pat/books/202080016400.5/2.html,转载请声明来源钻瓜专利网。